Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
CLINSQUARE: CLINICAL RESEARCH COURSES
Wednesday, April 24, 2024
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Facebook
Twitter
CLINSQUARE: Clinical Rsearch Courses by LIFEPRONOW
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
Home
Latest Pharma-News
Latest Pharma-News
Latest Pharma-News
FDA Takes Steps to Ensure Safety of Cinnamon Products Sold in the US
admin
-
March 8, 2024
Latest Pharma-News
FDA Clears First Over-the-Counter Continuous Glucose Monitor
admin
-
March 8, 2024
Latest Pharma-News
FDA, Industry Actions End Sales of PFAS Used in US Food Packaging
admin
-
March 1, 2024
Latest Pharma-News
Regulatory Applications Accepted in the U.S. and Japan for BMS Breyanzi in Relapsed or Refractory FL and Relapsed or Refractory MCL
admin
-
February 3, 2024
Latest Pharma-News
BlueRock Therapeutics exercises exclusive option to license iPSC cell therapy candidate OpCT-001 for Primary Photoreceptor Diseases
admin
-
February 1, 2024
Latest Pharma-News
No-fault compensation programme for COVID-19 vaccines is a world first
admin
-
February 22, 2021
0
Latest Pharma-News
FDA Warns 10 Companies for Illegally Selling Dietary Supplements Claiming to Treat Depression and Other Mental Health Disorders
admin
-
February 21, 2021
0
Latest Pharma-News
Exscientia and the University of Oxford announce partnership to develop treatments for Alzheimer’s disease
admin
-
February 20, 2021
0
Latest Pharma-News
Phase I Clinical Trial Authorisation for AVA6000 Approved by MHRA
admin
-
February 20, 2021
0
Latest Pharma-News
Efanesoctocog alfa granted FDA Fast Track Designation for treatment of hemophilia A
admin
-
February 19, 2021
0
Latest Pharma-News
From paper to digital pathway: WHO launches first ‘SMART Guidelines’
admin
-
February 19, 2021
0
Latest Pharma-News
USDA, FDA Underscore Current Epidemiologic and Scientific Information Indicating No Transmission of COVID-19 Through Food or Food Packaging
admin
-
February 19, 2021
0
Latest Pharma-News
EU approves Tukysa Combo for Advanced HER2-Positive Breast Cancer
admin
-
February 18, 2021
0
Latest Pharma-News
GSK announces gender and diversity aspirational targets to increase representation at senior levels
admin
-
February 18, 2021
0
Latest Pharma-News
The OlympiA Phase III trial for AstraZeneca and MSD’s Lynparza crossed superiority boundary
admin
-
February 18, 2021
0
Latest Pharma-News
WHO announces updates on new molecular assays for the diagnosis of TB and drug resistance
admin
-
February 18, 2021
0
Latest Pharma-News
FDA Approves First in the World, First-of-Its-Kind Implant for the Treatment of Rare Bone Disease as a Humanitarian Use Device
admin
-
February 18, 2021
0
1
...
69
70
71
...
144
Page 70 of 144
- Advertisment -
Most Read
FDA Takes Steps to Ensure Safety of Cinnamon Products Sold in the US
March 8, 2024
FDA Clears First Over-the-Counter Continuous Glucose Monitor
March 8, 2024
FDA, Industry Actions End Sales of PFAS Used in US Food Packaging
March 1, 2024
Regulatory Applications Accepted in the U.S. and Japan for BMS Breyanzi in Relapsed or Refractory FL and Relapsed or Refractory MCL
February 3, 2024